Antibody drug conjugates

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9498532
SERIAL NO

14203997

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to anti-FGFR2 and FGFR4 antibodies, antibody fragments, antibody drug conjugates, and their uses for the treatment of cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NOVARTIS AGLICHTSTRASSE 35 4056 BASEL SWITZERLAND

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Batt, David Bryant Wayland, US 10 148
Ettenberg, Seth Alexander Melrose, US 11 142
Haubst, Nicole Munich, DE 21 262
Hu, Tiancen Cambridge, US 20 656
Jenkins, David Carlisle, US 95 3906
Meyer, Matthew John Framingham, US 14 150
Petropoulos, Konstantin Munich, DE 6 70
Toksoz, Engin Munich, DE 8 74

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 22, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00